We are live on
!
Find out more
CCM
Crossvault Capital Management Portfolio holdings
AUM
$254M
1-Year Est. Return
5.07%
This Fund
S&P 500
This Quarter
Est. Return
+14.33%
1 Year Est. Return
-5.07%
3 Year Est. Return
+56.38%
5 Year Est. Return
+114.39%
10 Year Est. Return
–
AUM
$194M
AUM Growth
+$17.8M
(+10%)
Cap. Flow
-$4.78M
Cap. Flow
% of AUM
-2.46%
Top 10 Holdings %
Top 10 Hldgs %
45.6%
Holding
83
New
7
Increased
18
Reduced
28
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$5.1M |
| 2 |
XYZ
Block Inc
XYZ
|
+$2.33M |
| 3 |
Microsoft
MSFT
|
+$783K |
| 4 |
Netflix
NFLX
|
+$754K |
| 5 |
Workday
WDAY
|
+$493K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.22M |
| 2 |
Intel
INTC
|
+$5.06M |
| 3 |
UnitedHealth
UNH
|
+$1.4M |
| 4 |
Kraft Heinz
KHC
|
+$559K |
| 5 |
Abbott
ABT
|
+$527K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.55% |
| 2 | Technology | 17.16% |
| 3 | Healthcare | 13.03% |
| 4 | Consumer Discretionary | 13.03% |
| 5 | Financials | 11.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PES
76
DELISTED
Pioneer Energy Services Corp.
PES
| $64K | 0.03% |
+36,119
| New | +$62.2K |
|
|
77
Abbott
ABT
$187B
| – | – |
-7,289
| Closed | -$527K |
|
|
78
Bristol-Myers Squibb
BMY
$132B
| – | – |
-119,591
| Closed | -$6.22M |
|
|
79
Kraft Heinz
KHC
$30B
| – | – |
-12,996
| Closed | -$559K |
|
80
Coca-Cola
KO
$375B
| – | – |
-7,248
| Closed | -$343K |
|
81
Linde
LIN
$226B
| – | – |
-2,300
| Closed | -$359K |
|
82
Altria Group
MO
$114B
| – | – |
-8,095
| Closed | -$400K |
|
Similar funds
HA
PPW
SG
ETI
RIM
TF
TWM
IC
Crossvault Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Crossvault Capital Management held 83 positions worth $194M, up 10% from $176M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Crossvault Capital Management's Q1 2019 filing shows 7 new, 18 increased, 28 reduced and 6 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 12,385 shares worth $5.09M. The largest sale was Bristol-Myers Squibb, an estimated $6.22M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
- Crossvault Capital Management's largest Q1 2019 buy was Regeneron Pharmaceuticals: 12,385 shares worth $5.09M.
- Crossvault Capital Management added most to Block Inc in Q1 2019, an estimated $2.33M increase.
- Crossvault Capital Management's biggest Q1 2019 reduction was Intel, cutting an estimated $5.06M.
- Crossvault Capital Management fully exited Bristol-Myers Squibb in Q1 2019, selling an estimated $6.22M.
- Crossvault Capital Management's ten largest holdings make up 46% of its $194M portfolio in Q1 2019.
- Crossvault Capital Management opened 7 new positions and closed 6 in Q1 2019.
- Crossvault Capital Management's portfolio value rose 10% quarter-over-quarter to $194M.
Based on Crossvault Capital Management's 13F filing for Q1 2019, filed 24 Apr 2019.